Form 8-K - Current report:
SEC Accession No. 0000944809-21-000014
Filing Date
2021-02-18
Accepted
2021-02-18 16:07:13
Documents
16
Period of Report
2021-02-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20210218.htm   iXBRL 8-K 39288
2 EX-99.1 ex991-2x18x21.htm EX-99.1 92896
8 image_01.jpg GRAPHIC 260383
  Complete submission text file 0000944809-21-000014.txt   644841

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20210218.xsd EX-101.SCH 2448
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20210218_cal.xml EX-101.CAL 740
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20210218_def.xml EX-101.DEF 1686
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20210218_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20210218_pre.xml EX-101.PRE 12676
9 EXTRACTED XBRL INSTANCE DOCUMENT opk-20210218_htm.xml XML 10758
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 21649553
SIC: 2834 Pharmaceutical Preparations